Supernus Pharmaceuticals ... (SUPN)
Supernus Pharmaceuticals Max Pain By Strike
SUPN trades at $44.88, 40.3% above the near-term max pain of $32 expiring Sep 19, 2025 (25 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($8-$42), reflecting growing call interest at higher strikes. Key magnetic zone at 32 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Supernus Pharmaceuticals Max Pain By Expiry
Max pain for SUPN shows an upward trend from 8 to 42, suggesting bullish positioning in longer-dated options. The 113% spread signals divergent expectations across timeframes. Most levels below 44.88 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 32 | -12.88 (-28.70%) |
| Oct 17, 2025 | 42 | -2.88 (-6.42%) |
| Dec 19, 2025 | 32 | -12.88 (-28.70%) |
| Jan 16, 2026 | 8 | -36.88 (-82.17%) |
| Mar 20, 2026 | 37 | -7.88 (-17.56%) |